
Pharmaceutical Leaders Bring Patient Support Services In-House
A 23-point decline in third-party HUB service utilization signals a major strategic pivot for pharmaceutical manufacturers. According to the 2026 Patient Support Programs Trends report from Guidehouse, companies are increasingly insourcing patient journey management to exert greater control over data and service delivery amid mounting industry volatility.






















